What does MedStep do?

MedStep is a healthcare practice in Gent. Private Limited, started on 29 November 2012, 1 establishment.

What is the address of MedStep?

The registered office of MedStep is located at Denderlaan 1, 9000 Gent.

Is MedStep still active?

Yes. According to the CBE (31 October 2026) MedStep is active, legal situation “Normale toestand”, started on 29 November 2012.

Is MedStep registered on Peppol?

Yes, MedStep is registered on the Peppol network with ID 0208:0501766845.

What is the enterprise number of MedStep?

The enterprise number of MedStep is BE0501766845.

When was MedStep founded?

MedStep was founded on 29 November 2012.

Who are the directors of MedStep?

According to the 2025 annual accounts, the directors of MedStep are: Anneleen Dijkstra.

Is MedStep a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 November 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MedStep make in 2025?

MedStep posted a profit after taxes of € 12,287 in financial year 2025.

What is the revenue of MedStep?

As a small company, MedStep is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 28,745.

MedStep (Private Limited) - Gent - BE0501766845

Dossier MedStep, printed on 1 November 2026 from databakkes.be/en/0501766845/medstep. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MedStep from Gent, company number BE0501766845, closed financial year 2025 with a result of € 12,287 after tax. For that financial year MedStep recorded a gross margin of € 28,745 and equity of € 234,148. Compared with financial year 2024, the result moved from € 46,754 to € 12,287. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 20, 2026.

What it is worth Healthy

€ 234,148

▼ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 12,287

▼ 74% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 155,718

▼ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 47,327 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 15,313

▼ 18% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 30

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,845

▼ 23% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 81,425 Gross margin 2022: € 81,425 First fiscal year in the series	€ 62,296 Gross margin 2023: € 62,296 ▼ 23% vs 2022 (€ 81,425) Unfavourable step	€ 77,007 Gross margin 2024: € 77,007 ▲ 24% vs 2023 (€ 62,296) Favourable step	€ 28,745 Gross margin 2025: € 28,745 ▼ 63% vs 2024 (€ 77,007) Unfavourable step	▼ 63%
Profit after taxes	€ 51,022 Profit after taxes 2022: € 51,022 First fiscal year in the series	€ 36,335 Profit after taxes 2023: € 36,335 ▼ 29% vs 2022 (€ 51,022) Unfavourable step	€ 46,754 Profit after taxes 2024: € 46,754 ▲ 29% vs 2023 (€ 36,335) Favourable step	€ 12,287 Profit after taxes 2025: € 12,287 ▼ 74% vs 2024 (€ 46,754) Unfavourable step	▼ 74%
Equity	€ 204,147 Equity 2022: € 204,147 First fiscal year in the series	€ 240,482 Equity 2023: € 240,482 ▲ 18% vs 2022 (€ 204,147) Favourable step	€ 269,187 Equity 2024: € 269,187 ▲ 12% vs 2023 (€ 240,482) Favourable step	€ 234,148 Equity 2025: € 234,148 ▼ 13% vs 2024 (€ 269,187) Unfavourable step	▼ 13%
Total debts	€ 15,846 Total debts 2022: € 15,846 First fiscal year in the series	€ 14,968 Total debts 2023: € 14,968 ▼ 6% vs 2022 (€ 15,846) Favourable step	€ 12,241 Total debts 2024: € 12,241 ▼ 18% vs 2023 (€ 14,968) Favourable step	€ 2,120 Total debts 2025: € 2,120 ▼ 83% vs 2024 (€ 12,241) Favourable step	▼ 83%
Cash	€ 155,554 Cash 2022: € 155,554 First fiscal year in the series	€ 182,703 Cash 2023: € 182,703 ▲ 17% vs 2022 (€ 155,554) Favourable step	€ 234,908 Cash 2024: € 234,908 ▲ 29% vs 2023 (€ 182,703) Favourable step	€ 155,718 Cash 2025: € 155,718 ▼ 34% vs 2024 (€ 234,908) Unfavourable step	▼ 34%
Land & buildings	€ 3,143 Land & buildings 2022: € 3,143 First fiscal year in the series	€ 2,445 Land & buildings 2023: € 2,445 ▼ 22% vs 2022 (€ 3,143) Unchanged	€ 1,746 Land & buildings 2024: € 1,746 ▼ 29% vs 2023 (€ 2,445) Unchanged	€ 40,881 Land & buildings 2025: € 40,881 ▲ € 39,135 vs 2024 (€ 1,746) Unchanged	▲ € 39,135
Retained profit	€ 197,947 Retained profit 2022: € 197,947 First fiscal year in the series	€ 234,282 Retained profit 2023: € 234,282 ▲ 18% vs 2022 (€ 197,947) Favourable step	€ 262,987 Retained profit 2024: € 262,987 ▲ 12% vs 2023 (€ 234,282) Favourable step	€ 227,948 Retained profit 2025: € 227,948 ▼ 13% vs 2024 (€ 262,987) Unfavourable step	▼ 13%
Dividend	€ 72,125 Dividend 2022: € 72,125 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 72,125) Unchanged	€ 18,048 Dividend 2024: € 18,048 Unchanged (€ 0) Unchanged	€ 47,327 Dividend 2025: € 47,327 ▲ 162% vs 2024 (€ 18,048) Unchanged	▲ 162%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 30 Bank debt 2024: € 30 Unchanged (€ 0) Unfavourable step	€ 30 Bank debt 2025: € 30 Unchanged (€ 30) Unchanged
Balance sheet total	€ 219,993 Balance sheet total 2022: € 219,993 First fiscal year in the series	€ 255,450 Balance sheet total 2023: € 255,450 ▲ 16% vs 2022 (€ 219,993) Unchanged	€ 281,428 Balance sheet total 2024: € 281,428 ▲ 10% vs 2023 (€ 255,450) Unchanged	€ 236,269 Balance sheet total 2025: € 236,269 ▼ 16% vs 2024 (€ 281,428) Unchanged	▼ 16%

Key figures of MedStep, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to MedStep?

What happened at MedStep in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 20, 2026 New annual accounts for financial year 2025: profit of € 12,287 (▼ 74% vs 2024). Source: NBB ↗
Nov 29, 2012 New establishment in Gent. KBO
Nov 29, 2012 Start of the company according to the CBE. KBO

In short

From € 51,022 profit in 2022 to € 12,287 profit in 2025.

Paid € 59,324 in corporate taxes since 2022.

Best year ever: 2022, with € 51,022 profit.

Paid out € 137,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Anneleen Dijkstra

MedStep

Behind MedStep is Anneleen Dijkstra.

Directors

According to the 2025 annual accounts

Anneleen Dijkstra

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Denderlaan 1

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0501.766.845

VAT number

BE 0501.766.845

Registered office

Denderlaan 1, 9000 Gent

Names & denominations

MedStep

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

29 November 2012

Peppol

Active · Active since 31 Oct 2023

Activities · NACE

Activiteiten op het gebied van psychologie

Activiteiten op het vlak van geestelijke gezondheidszorg, m.u.v. psychiatrische ziekenhuizen en verzorgingstehuizen

View on CBE Public ↗ Annual accounts (NBB) ↗

MedStep

Financials

What happened to MedStep?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions